Hong Kong · Delayed Price · Currency is HKD Brii Biosciences Statistics
Total Valuation
HKG:2137 has a market cap or net worth of HKD 1.46 billion. The enterprise value is -876.86 million.
| Market Cap | 1.46B |
| Enterprise Value | -876.86M |
Important Dates
The last earnings date was Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2137 has 719.38 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | 719.38M |
| Shares Outstanding | 719.38M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 4.94% |
| Owned by Institutions (%) | 0.33% |
| Float | 549.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.86 |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 42.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 42.98 |
| Quick Ratio | 42.97 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -81.95 |
Financial Efficiency
Return on equity (ROE) is -14.42% and return on invested capital (ROIC) is -6.37%.
| Return on Equity (ROE) | -14.42% |
| Return on Assets (ROA) | -6.24% |
| Return on Invested Capital (ROIC) | -6.37% |
| Return on Capital Employed (ROCE) | -11.02% |
| Revenue Per Employee | 1.37M |
| Profits Per Employee | -4.20M |
| Employee Count | 98 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +111.46% in the last 52 weeks. The beta is 1.42, so HKG:2137's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | +111.46% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 50.10 |
| Average Volume (20 Days) | 9,504,733 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2137 had revenue of HKD 134.48 million and -411.68 million in losses. Loss per share was -0.56.
| Revenue | 134.48M |
| Gross Profit | 134.48M |
| Operating Income | -294.28M |
| Pretax Income | -414.20M |
| Net Income | -411.68M |
| EBITDA | -293.13M |
| EBIT | -294.28M |
| Loss Per Share | -0.56 |
Balance Sheet
The company has 2.29 billion in cash and 8.10 million in debt, giving a net cash position of 2.28 billion or 3.17 per share.
| Cash & Cash Equivalents | 2.29B |
| Total Debt | 8.10M |
| Net Cash | 2.28B |
| Net Cash Per Share | 3.17 |
| Equity (Book Value) | 2.67B |
| Book Value Per Share | 3.68 |
| Working Capital | 2.24B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -218.82% |
| Pretax Margin | -307.99% |
| Profit Margin | n/a |
| EBITDA Margin | -217.97% |
| EBIT Margin | -218.82% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2137 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | n/a |
| Earnings Yield | -28.19% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |